Petitioner's Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit | Apr 25, 2018 | PAPER | PETITIONER |
Pfizer, Inc's Notice of Appeal | Apr 25, 2018 | PAPER | PETITIONER |
Termination Decision Document | Feb 21, 2018 | PAPER | BOARD |
Updated Mandatory Notice | Feb 2, 2018 | PAPER | PETITIONER |
Patent Owners' Updated Mandatory Notice | Dec 27, 2017 | PAPER | PATENT OWNER |
Hearing Transcript | Dec 19, 2017 | PAPER | BOARD |
Patent Owners' Objections to Petitioners' 10/26 Demonstrative Slides | Oct 30, 2017 | PAPER | PATENT OWNER |
Patent Owners' Objections to Petitioners' Demonstrative Slides | Oct 26, 2017 | PAPER | PATENT OWNER |
Petitioners Reply in Support of Motion to Exclude Evidence | Oct 12, 2017 | PAPER | PETITIONER |
Patent Owners' Reply in Support of Motion to Exclude Evidence | Oct 12, 2017 | PAPER | PATENT OWNER |
Trial Hearing Order | Oct 6, 2017 | PAPER | BOARD |
Petitioners Opposition to Patent Owner Motion to Exclude Evidence | Oct 5, 2017 | PAPER | PETITIONER |
Petitioners Opposition to Patent Owner Motion for Observations on Cross Examination | Oct 5, 2017 | PAPER | PETITIONER |
Petitioners Updated Exhibit List | Oct 5, 2017 | PAPER | PETITIONER |
Declaration of Vibeke Strand, M.D., MACR, FACP | Oct 5, 2017 | EXHIBIT | PETITIONER |
Declaration of Maarten Boers Regarding Certain Exhibits Relied Upon By Petitioners | Oct 5, 2017 | EXHIBIT | PETITIONER |
Genentech, Inc.¿¿¿s Response To Petitioner¿¿¿s Additional Discovery | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (1 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (2 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (3 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (7 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (2 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (4 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (5 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (6 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (8 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
European Patent Office File History for the Opposition to EP1176981 (9 of 9) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (1 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (3 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (4 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (5 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (6 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (7 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (8 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (9 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (10 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (11 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (12 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent 7,820,161 (13 of 13) | Oct 5, 2017 | EXHIBIT | PETITIONER |
Patent Owner's Opposition to Motion to Exclude Evidence | Oct 5, 2017 | PAPER | PATENT OWNER |
Petitioners' Motion to Exclude Evidence | Sep 29, 2017 | PAPER | PETITIONER |
Petitioner's Request for Oral Hearing | Sep 29, 2017 | PAPER | PETITIONER |
Patent Owners' Motion for Observations on Cross Examination | Sep 29, 2017 | PAPER | PATENT OWNER |
Ex 2086 Second Edwards Declaration | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2087 Edwards Testimony - Day 2 | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2088 Patient Info | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2089 Patient Consent Form | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Patent Owners' Motion to Exclude Evidence | Sep 29, 2017 | PAPER | PATENT OWNER |
Ex 2090 Patient Records | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2091 Leandro | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2092 Edwards Depo Transcript 2017-09-22 | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Ex 2093 Boers Depo Transcript 2017-09-21 | Sep 29, 2017 | EXHIBIT | PATENT OWNER |
Patent Owners' Updated Exhibit List | Sep 29, 2017 | PAPER | PATENT OWNER |
Patent Owners' Request for Oral Hearing | Sep 29, 2017 | PAPER | PATENT OWNER |
Notice of Joint Stipulation to Modify Due Date 4 & 5 | Sep 15, 2017 | PAPER | PATENT OWNER |
Modifying Scheduling Order | Sep 14, 2017 | PAPER | BOARD |
Notice of Deposition of Maarten Boers | Sep 12, 2017 | PAPER | PATENT OWNER |
Notice of Deposition of Jonathan Edwards | Sep 12, 2017 | PAPER | PATENT OWNER |
Patent Owners' Objections to Exhibits | Aug 30, 2017 | PAPER | PATENT OWNER |
Notice of Deposition of Jonathan Edwards | Aug 24, 2017 | PAPER | PATENT OWNER |
Notice of Deposition of Maarten Boers | Aug 24, 2017 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owners' Response | Aug 23, 2017 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Aug 23, 2017 | PAPER | PETITIONER |
Prosecution History for U.S. Patent 7,820,161 (Part 1 of 2) | Aug 23, 2017 | EXHIBIT | PETITIONER |
Prosecution History for U.S. Patent 7,820,161 (Part 2 of 2) | Aug 23, 2017 | EXHIBIT | PETITIONER |
Strand et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
IPR2016-01614, Deposition Transcript of Gregg Silverman | Aug 23, 2017 | EXHIBIT | PETITIONER |
Declaration of Maarten M. Boers, M.D. | Aug 23, 2017 | EXHIBIT | PETITIONER |
O¿¿¿Dell | Aug 23, 2017 | EXHIBIT | PETITIONER |
Koopman et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
De Clerck | Aug 23, 2017 | EXHIBIT | PETITIONER |
Edwards et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Kim et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Smolen et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Klareskog et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
St. Clair et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Storz | Aug 23, 2017 | EXHIBIT | PETITIONER |
Curriculum Vitae of Maarten M. Boers | Aug 23, 2017 | EXHIBIT | PETITIONER |
Declaration of Jonathan Charles Wright Edwards | Aug 23, 2017 | EXHIBIT | PETITIONER |
Kirwan | Aug 23, 2017 | EXHIBIT | PETITIONER |
Mottonen et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Van Der Heijde et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Rituxan Dosage and Administration Change | Aug 23, 2017 | EXHIBIT | PETITIONER |
Rituxan Warnings Change | Aug 23, 2017 | EXHIBIT | PETITIONER |
IPR2016-01614 | Aug 23, 2017 | EXHIBIT | PETITIONER |
IPR2016-01614, Biogen, Inc.¿¿¿s Response to Petitioner¿¿¿s Additional
Discovery | Aug 23, 2017 | EXHIBIT | PETITIONER |
Silverman et al. | Aug 23, 2017 | EXHIBIT | PETITIONER |
Moreland | Aug 23, 2017 | EXHIBIT | PETITIONER |
EXPUNGED | Aug 14, 2017 | PAPER | PETITIONER |
Petitioner Pfizer, Inc.'s Mandatory Notice | Aug 14, 2017 | PAPER | PETITIONER |
Petitioners Notice of Deposition of Dr. Gregg Silverman | Jul 26, 2017 | PAPER | PETITIONER |
Petitioners Notice of Deposition of Dr. Ryan Sullivan | Jul 26, 2017 | PAPER | PETITIONER |
Decision Institution of Inter Partes Review, Grant of Motion for Joinder, and Grant of Joint Motion to Dismiss Certain Challenges in the Petition | Jul 18, 2017 | PAPER | BOARD |
DECISION Granting Patent Owner's Motion to Seal and Entry of Protective Order | Jul 11, 2017 | PAPER | BOARD |
Conduct of the Proceeding | Jul 7, 2017 | PAPER | BOARD |
Decision Granting Petitioner's Motion for Additional Discovery | Jul 7, 2017 | PAPER | BOARD |
Patent Owners' Opposition to Petitioner's Motion for Additional Discovery | Jun 16, 2017 | PAPER | PATENT OWNER |
Petitioner's Objections to Exhibits Under 37 C.F.R. s. 42.64 | Jun 9, 2017 | PAPER | PETITIONER |
Petitioner's Motion for Additional Discovery Under 37 C.F.R. s. 42.51(b)(2) | Jun 9, 2017 | PAPER | PETITIONER |
Ex 2002 Panayi 1992 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2004 Boers 1991 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2007 Felson 1994 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2011 Dwosh 1983 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2014 Gioud-Paquet 1987 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2016 Boers Transcript 05-10-17 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2018 Panayi 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2019 Boers 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2022 Manz 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2025 Current Rituxan Label | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2026 PDR 2009 Rituxam | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2038 Goldring 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2003 Kelly | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2005 Tak 2012 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2006 Cohen 2010 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2008 Boers 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2009 McLaughlin 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2010 Slifka 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2012 Harris 1961 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2013 Kallerup 1979 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2015 Chustecka 2004 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2017 IPR2015-01744 Petition | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2020 Amendment Response | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2021 Manz 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2023 Kelley Chapters | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2024 Edward 2002 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2027 Smyth 1975 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2028 Edwards 2001 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2029 Chusteka Declaration and Attachment | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2030 Allowance 2010-03-17 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2031 Schulze 2000 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2032 Weinblatt 1995 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2033 Carson 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2034 Reininger 1990 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2035 Pascual 1990 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2036 Radoux 1986 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2037 PDR 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2039 Moreland 1995 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2040 Gaffney 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2041 Sany 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2042 Gaston Declaration | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2043 Cambridge 2015 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2045 Massarotti 2005 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2048 Keystone 2003 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2051 Genentech 10-K | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2053 Choy 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2055 Restriction Requirement 2002-05-17 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2056 Janeway Immunobiology | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2059 Lahita | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2044 Massarotti 2005 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2046 Massarotti | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2047 CFR 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2049 Keystone 2002 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2050 Lu Declaration | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2052 Lipsky | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2053 Choy 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2054 Bulpitt 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2057 Fusconi 2011 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2058 McKay | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2064 Takahashi 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2060 Woodcock 2011 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2061 Williams 1994 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2062 Smolen 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2063 Gopal 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2067 McHeyzer April 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2065 Gray 1993 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2066 Perlman 2016 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2069 Morris 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2070 Guinamard 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2072 Kim 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2068 Zheng 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2071 Puthier 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2075 Kavanaugh 1997 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2079 Van den Bosch 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2073 Carson 1987 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2074 Carson 1990 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2076 Wendling 1996 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2077 Olsen 1996 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2078 Van der Lubbe 1995 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2080 St Clair, Journal of Rheumatology 2000 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2081 Lorenz 1999 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2083 Silverman CV | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2082 Lorenz 1998 | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner Response (redacted) | Jun 2, 2017 | PAPER | PATENT OWNER |
Ex 2085 Silverman Declaration | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Jun 2, 2017 | PAPER | PATENT OWNER |
Patent Owner Response (unredacted) | Jun 2, 2017 | PAPER | PATENT OWNER |
Ex 2084 Sullivan Declaration (unredacted) | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Ex 2084 Sullivan Declaration (redacted) | Jun 2, 2017 | EXHIBIT | PATENT OWNER |
Motion to Seal | Jun 2, 2017 | PAPER | PATENT OWNER |
Notice of Deposition of Maarten Boers | Apr 25, 2017 | PAPER | PATENT OWNER |
ORDER Conduct of the Proceeding | Apr 11, 2017 | PAPER | BOARD |
Order Conduct of the Proceeding | Mar 30, 2017 | PAPER | BOARD |
Notice of Joint Stipulation to Modify Due Dates | Mar 30, 2017 | PAPER | PATENT OWNER |
Notice of Filing | Mar 24, 2017 | PAPER | PATENT OWNER |
Ex 2001 Gindler PHV Declaration | Mar 24, 2017 | EXHIBIT | PATENT OWNER |
Decision Granting Motions for Pro Hac Vice Recognition of Ms. Elaine Herrmann Blais and Mr. Robert V. Cerwinski | Mar 23, 2017 | PAPER | BOARD |
Decision Granting Motion for Pro Hac Vice Recognition of Mr. David Gindler | Mar 23, 2017 | PAPER | BOARD |
Conduct of the Proceeding | Mar 23, 2017 | PAPER | BOARD |
Patent Owners' Objections to Exhibits | Mar 10, 2017 | PAPER | PATENT OWNER |
Trial Instituted Document | Feb 24, 2017 | PAPER | BOARD |
Scheduling order | Feb 24, 2017 | PAPER | BOARD |
Pro Hac Vice Motion/Declaration (Gindler) | Dec 8, 2016 | PAPER | PATENT OWNER |
Petitioners Updated Mandatory Notices | Oct 24, 2016 | PAPER | PETITIONER |
Motion for Pro Hac Vice Admission of E. Herrmann Blais | Sep 12, 2016 | PAPER | PETITIONER |
Affidavit of E. Herrmann Blais in Support of Motion for PHV | Sep 12, 2016 | EXHIBIT | PETITIONER |
Affidavit of Robert V. Cerwinski in Support of Motion for PHV Admission | Sep 12, 2016 | EXHIBIT | PETITIONER |
Petitioner's Motion for PHV Admission of Robert V. Cerwinski | Sep 12, 2016 | PAPER | PETITIONER |
Celltrion, Inc.'s Updated Exhibit List | Sep 12, 2016 | PAPER | PETITIONER |
Power of Attorney | Sep 6, 2016 | PAPER | PATENT OWNER |
Patent Owners Mandatory Notice | Sep 6, 2016 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Aug 30, 2016 | PAPER | BOARD |
Corrected Certificate of Service for Petition and Power of Attorney | Aug 16, 2016 | PAPER | PETITIONER |
Celltrion, Inc.'s Power of Attorney | Aug 15, 2016 | PAPER | PETITIONER |
Petition for Inter Partes Review No. IPR 2016-01614 | Aug 15, 2016 | PAPER | PETITIONER |
Declaration of Maarten M. Boers, M.D. | Aug 15, 2016 | EXHIBIT | PETITIONER |
Second Declaration of Ronald F. van Vollenhoven, dated January 19, 2010 | Aug 15, 2016 | EXHIBIT | PETITIONER |
U.S. Patent 7820161 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Curriculum Vitae of Maarten M. Boers, M.D. | Aug 15, 2016 | EXHIBIT | PETITIONER |
Eisenberg letter to Genetech Oncology & IDEC | Aug 15, 2016 | EXHIBIT | PETITIONER |
Gryn letter to Parker, dated May 6, 1998 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Saleh letter to Comprehensive Cancer Center, dated October 1, 1998 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Latov letter to Horvath, dated November 16, 1998 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Pestronk letter to Department of Neurology, dated October 12, 1998 | Aug 15, 2016 | EXHIBIT | PETITIONER |
American College of Rheumatology Subcommittee | Aug 15, 2016 | EXHIBIT | PETITIONER |
ODell, Methotrexate Use (1997) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Boers World Health Organization | Aug 15, 2016 | EXHIBIT | PETITIONER |
Felson American College of Rheumatology | Aug 15, 2016 | EXHIBIT | PETITIONER |
Kremer, Combination Therapy with Biologic Agents in Rheumatoid Arthritis | Aug 15, 2016 | EXHIBIT | PETITIONER |
Guidance for Industry Clinical Development Programs for Drugs | Aug 15, 2016 | EXHIBIT | PETITIONER |
Looney letter to Dutcher, dated January 15, 1999 | Aug 15, 2016 | EXHIBIT | PETITIONER |
T. Pincus & C.M. Stein, "No evidence of disease" in rheumatoid arthritis | Aug 15, 2016 | EXHIBIT | PETITIONER |
William Schwieterman FDA Conversation | Aug 15, 2016 | EXHIBIT | PETITIONER |
Kremer, Methotrexate for Rheumatoid Arthritis | Aug 15, 2016 | EXHIBIT | PETITIONER |
Boers et al.,The Lancet, 350:309-18 (1997) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Maini et al.,Arthritis & Rheumatism | Aug 15, 2016 | EXHIBIT | PETITIONER |
First Declaration of Ronald F. van Vollenhoven, dated July 30, 2007 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Weinblatt et al.,New England Journal of Medicine | Aug 15, 2016 | EXHIBIT | PETITIONER |
IPR2015-00415 Patent Owner's Preliminary Response | Aug 15, 2016 | EXHIBIT | PETITIONER |
MaloneyPhase 1 Clinical Trial Using Escalating Single-Dose Infusion (1994) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Maloney. IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy (1997) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Maloney et al., IDEC-C2B8 (1997)(2) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Edwards, The Predictable Effect of Small Immune Complexes (1998) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Letter from the Medicines Control Agency to Edwards | Aug 15, 2016 | EXHIBIT | PETITIONER |
Rituxan Label 1997 | Aug 15, 2016 | EXHIBIT | PETITIONER |
FDA, 64 Fed. Reg. 7898 (1999) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Buch, Updated consensus statement on the use of rituximab | Aug 15, 2016 | EXHIBIT | PETITIONER |
Wendler, Rituximab in practice | Aug 15, 2016 | EXHIBIT | PETITIONER |
Edwards, Efficacy of B-Cell–Targeted Therapy (2004) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Klareskog, double-blind randomised controlled trial | Aug 15, 2016 | EXHIBIT | PETITIONER |
Bathon, Comparison of Etanercept and Methotrexate (2000) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Decision of the European Patent Office re: EP1179681 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Kalden, Rescue of DMARD Failures by Means of Monoclonal Antibodies | Aug 15, 2016 | EXHIBIT | PETITIONER |
FDA, Rituxan Approval Letter, 97-0244, (November 26, 1997) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Baht WO 95/03770 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Declaration of Jack Goldberg, M.D., FACP | Aug 15, 2016 | EXHIBIT | PETITIONER |
Edwards, The Case for Killing Cells with ANTI-CD20 in RA | Aug 15, 2016 | EXHIBIT | PETITIONER |
Declaration by Sarah Fink | Aug 15, 2016 | EXHIBIT | PETITIONER |
The University College London Hospitals, October 30, 1998, Letter | Aug 15, 2016 | EXHIBIT | PETITIONER |
The Joint UCL/UCLH Committees on the Ethics of Human Research, | Aug 15, 2016 | EXHIBIT | PETITIONER |
Information for patients undergoing treatment of rheumatoid arthritis | Aug 15, 2016 | EXHIBIT | PETITIONER |
Kremer (1995) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Declaration by Jonathan Charles Wright Edwards | Aug 15, 2016 | EXHIBIT | PETITIONER |
Moreland Etanercept Therapy in Rheumatoid Arthritis | Aug 15, 2016 | EXHIBIT | PETITIONER |
Remicade Label 1998 | Aug 15, 2016 | EXHIBIT | PETITIONER |
Gabriel, The Epidemiology of Rheumatoid Arthritis (2001) | Aug 15, 2016 | EXHIBIT | PETITIONER |
Curriculum Vitae of Jack Goldberg, M.D., F.A.C.P. | Aug 15, 2016 | EXHIBIT | PETITIONER |
Declaration from Internet Archive | Aug 15, 2016 | EXHIBIT | PETITIONER |
Drugs@FDA: FDA Application No. (BLA) 103705 | Aug 15, 2016 | EXHIBIT | PETITIONER |
1997 Form 10-K405/A filed by IDEC Pharmaceuticals | Aug 15, 2016 | EXHIBIT | PETITIONER |
Internet Archive Capture of Genentech Website for Rituxan | Aug 15, 2016 | EXHIBIT | PETITIONER |
ODell, Treatment of Rheumatoid Arthritis with Methotrexate Alone | Aug 15, 2016 | EXHIBIT | PETITIONER |